跳至主要内容
临床试验/NCT03201549
NCT03201549已完成不适用

The Effects of Increased Fructose Ingestion on FGF-21 Levels in Humans

Beth Israel Deaconess Medical Center2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2017年7月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
2
主要终点
Change in serum FGF21 levels

研究概览

简要总结

The primary aim of this study is to examine the effect of fructose ingestion on serum FGF-21 levels in humans.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Ages 18-60
  • BMI 19-25 kg/m2; 19-23 for Asian subjects
  • Stable weight (variation < 3 kg within 6 months of screening visit)
  • Ability to give informed consent in English
  • Use of medically approved form of contraception

排除标准

  • Fasting blood glucose >100
  • Hemoglobin A1C% > 6.5%
  • Fasting triglycerides >150
  • Type 1 or type 2 diabetes mellitus diagnosed according to American Diabetes Association criteria
  • Coronary heart disease (history of myocardial infarction, unstable angina pectoris, or congestive heart failure)
  • Uncontrolled hypertension (BP > 160/100 mmHg on or off antihypertensive medication) intravenous drug use
  • Recent weight loss (> 3 kg within 6 months of the screening visit)
  • Gastroparesis
  • Inflammatory or irritable bowel disease
  • Malignancy treated with chemotherapy within the past 3 years
  • Depression or psychosis requiring hospitalization
  • Renal insufficiency (creatinine clearance < 40 ml/min)
  • Transaminases > 2x above the normal range
  • Known liver disease
  • Pregnancy within 6 months of the screening visit
  • Lactation
  • Failure to use medically approved contraceptive methods
  • History of surgery for the treatment of obesity (gastric banding, gastric bypass, gastric stapling)
  • Change in dose of thyroid hormone or antithyroidal medication within 3 months of screening visit
  • History of alcohol abuse within the past 5 years
  • Fructose intolerance
  • Exclusionary medications:
  • Oral steroids
  • Metformin
  • Weight loss medications including nonprescription supplements

结局指标

主要结局

Change in serum FGF21 levels

时间窗: 2 weeks

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jody Dushay

Assistant Professor of Medicine

Beth Israel Deaconess Medical Center

研究点 (2)

Loading locations...

相似试验

The Effects of Increased Fructose Ingestion on... | 临床试验